BioDiem Ltd. has been lucratively granted patent for BDM-I, a synthetic antimicrobial compound, reveals a recent report, the announcement for which has been made today by the company.

The report says that the granting of patent signifies that the amalgam BDM-I is now restricted to BioDiem for being used as a treatment for vulvovaginitis. Vulvovaginitis is a kind of soreness that occurs in a person's vulva or vagina.